SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancerSALZMAN, David W; WEIDHAAS, Joanne B.Pharmacology & therapeutics (Oxford). 2013, Vol 137, Num 1, pp 55-63, issn 0163-7258, 9 p.Article

Postmastectomy Radiation Therapy for Lymph Node-Negative, Locally Advanced Breast Cancer After Modified Radical Mastectomy : Analysis of the NCl Surveillance, Epidemiology, and End Results DatabaseYU, James B; WILSON, Lynn D; DASGUPTA, Tina et al.Cancer. 2008, Vol 113, Num 1, pp 38-47, issn 0008-543X, 10 p.Article

A conserved RAS/mitogen-activated protein kinase pathway regulates DNA damage-induced cell death postirradiation in radelegansWEIDHAAS, Joanne B; EISENMANN, David M; HOLUB, Justin M et al.Cancer research (Baltimore). 2006, Vol 66, Num 21, pp 10434-10438, issn 0008-5472, 5 p.Article

Characteristics and Outcomes of Breast Cancer in Women With and Without a History of Radiation for Hodgkin's Lymphoma: A Multi-Institutional, Matched Cohort StudyELKIN, Elena B; KLEM, Michelle L; CONSTINE, Louis S et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2466-2473, issn 0732-183X, 8 p.Article

Common variants at 19p13 are associated with susceptibility to ovarian cancerBOLTON, Kelly L; TYRER, Jonathan; WEIDHAAS, Joanne et al.Nature genetics. 2010, Vol 42, Num 10, pp 880-884, issn 1061-4036, 5 p.Article

microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional AnalysisHOFFMAN, Aaron E; TONGZHANG ZHENG; CHUNHUI YI et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 14, pp 5970-5977, issn 0008-5472, 8 p.Article

Breast Sentinel Lymph Node Dissection Before Preoperative Chemotherapy. DiscussionGRUBE, Baiba J; CHRISTY, Carla J; HIGGINS, Susan A et al.Archives of surgery (Chicago, IL. 1960). 2008, Vol 143, Num 7, pp 692-700, issn 0004-0010, 9 p.Article

Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancerHAFFTY, Bruce G; QIFENG YANG; REISS, Michael et al.Journal of clinical oncology. 2006, Vol 24, Num 36, pp 5652-5657, issn 0732-183X, 6 p.Article

MicroRNAs as Potential Agents to Alter Resistance to Cytotoxic Anticancer TherapyWEIDHAAS, Joanne B; BABAR, Imran; NALLUR, Sunitha M et al.Cancer research (Baltimore). 2007, Vol 67, Num 23, pp 11111-11116, issn 0008-5472, 6 p.Article

A Let-7 MicroRNA SNP in the KRAS 3'UTR Is Prognostic in Early-Stage Colorectal CancerSMITS, Kim M; PARANJAPE, Trupti; NALLUR, Sunitha et al.Clinical cancer research (Print). 2011, Vol 17, Num 24, pp 7723-7731, issn 1078-0432, 9 p.Article

A let-7 microRNA-Binding Site Polymorphism in KRAS Predicts Improved Outcome in Patients with Metastatic Colorectal Cancer Treated with Salvage Cetuximab/ Panitumumab MonotherapySARIDAKI, Zenia; WEIDHAAS, Joanne B; PILATI, Camilla et al.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4499-4510, issn 1078-0432, 12 p.Article

Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer familiesHOLLESTELLE, Antoinette; PELLETIER, Cory; AULCHENKO, Yurii S et al.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 79-84, issn 0167-6806, 6 p.Article

A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer RiskRATNER, Elena; LINGENG LU; PEI HUI et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 16, pp 6509-6515, issn 0008-5472, 7 p.Article